2008
DOI: 10.1111/j.1439-0507.2008.01617.x
|View full text |Cite
|
Sign up to set email alerts
|

Topical treatment of intertriginous candidal infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
5
0
1

Year Published

2011
2011
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 0 publications
2
5
0
1
Order By: Relevance
“…As seen in previous case reports, a 2‐week treatment regimen with Travocort cream (containing the imidazole ISN 0.1% and the corticosteroid diflucortolone valerate) was effective in improving the clinical signs of tinea pedis and in alleviating the symptoms that most impacted the patient's QoL. Furthermore, the regimen was safe for use in patients with diabetes consistent with previous reports . ISN has a broad spectrum of antimicrobial activity against dermatophytes, pathogenic yeasts, filamentous fungi, moulds and gram‐positive bacteria .…”
Section: Discussionsupporting
confidence: 86%
“…As seen in previous case reports, a 2‐week treatment regimen with Travocort cream (containing the imidazole ISN 0.1% and the corticosteroid diflucortolone valerate) was effective in improving the clinical signs of tinea pedis and in alleviating the symptoms that most impacted the patient's QoL. Furthermore, the regimen was safe for use in patients with diabetes consistent with previous reports . ISN has a broad spectrum of antimicrobial activity against dermatophytes, pathogenic yeasts, filamentous fungi, moulds and gram‐positive bacteria .…”
Section: Discussionsupporting
confidence: 86%
“…In this patient, the intertrigo due to C. albicans led to discomfort in the form of severe pruritus. As seen in previous case reports, a 7‐day treatment regimen with Travocort completely alleviated the pruritus associated with candidal intertrigo and was well tolerated. ISN is an imidazole antifungal agent, and along with the corticosteroid DFV, is the active ingredient in the topical drug Travocort.…”
Section: Discussionsupporting
confidence: 79%
“…Xerostomia, hyperhidrosis, occlusive wearings, occupational factors, use of corticosteroids or wide spectrum antibiotics, and immunosuppression including HIV infection may also increase the risk. 3 , 51 , 68 , 88 , 89…”
Section: Candidal Intertrigomentioning
confidence: 99%